NorthWest Biotherapeutics Inc (NWBO)

[MalteseFalcon]

One thing not to overlook is that the balance sheet of NWBO has been precarious with the company lurching from financing to financing. This lack of cash and continued dilutions has kept many potential investors away.

Today's news will likely change that as it becomes apparent to the market that this is a groundbreaking technology. The stock, in all probability, will surge and as it does warrants issued in the various deals will be converted to shares not only by long but also by shorts. A rising stock price will force many of those short the stock and long the warrants to convert to cover their positions. This will raise millions for the company.

In addition, the company recently said there was pending financing news. Hopefully, there will soon be news on this.

So a combination of warrants being exercised and a financing will substantially de-risk the company, attract new investors and likely lead to a further valuation lift for NWBO.